MET and ovarian carcinoma: However, to our knowledge, there is currently no comprehensive study on the relative expression, cellular location and prognostic significance of all members of the HER family, c-MET, IGF-1R, and the putative ovarian cancer stem cell biomarker in patients with ovarian cancer.